1. Home
  2. TUYA vs EVO Comparison

TUYA vs EVO Comparison

Compare TUYA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUYA
    SELLHOLDBUYas of 20 hours ago
  • EVO
    SELLHOLDBUYas of 20 hours ago
  • Stock Information
  • Founded
  • TUYA 2014
  • EVO 1993
  • Country
  • TUYA China
  • EVO Germany
  • Employees
  • TUYA N/A
  • EVO N/A
  • Industry
  • TUYA Computer Software: Prepackaged Software
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TUYA Technology
  • EVO Health Care
  • Exchange
  • TUYA Nasdaq
  • EVO Nasdaq
  • Market Cap
  • TUYA 1.5B
  • EVO 1.6B
  • IPO Year
  • TUYA 2021
  • EVO 2021
  • Fundamental
  • Price
  • TUYA $3.03
  • EVO $3.36
  • Analyst Decision
  • TUYA
  • EVO Buy
  • Analyst Count
  • TUYA 0
  • EVO 2
  • Target Price
  • TUYA N/A
  • EVO $5.90
  • AVG Volume (30 Days)
  • TUYA 3.5M
  • EVO 114.9K
  • Earning Date
  • TUYA 05-19-2025
  • EVO 05-21-2025
  • Dividend Yield
  • TUYA 3.60%
  • EVO N/A
  • EPS Growth
  • TUYA N/A
  • EVO N/A
  • EPS
  • TUYA 0.01
  • EVO N/A
  • Revenue
  • TUYA $298,617,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • TUYA $22.50
  • EVO $3.70
  • Revenue Next Year
  • TUYA $18.47
  • EVO $10.32
  • P/E Ratio
  • TUYA $355.42
  • EVO N/A
  • Revenue Growth
  • TUYA 29.84
  • EVO N/A
  • 52 Week Low
  • TUYA $1.28
  • EVO $2.85
  • 52 Week High
  • TUYA $4.63
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • TUYA 40.22
  • EVO 33.58
  • Support Level
  • TUYA $3.32
  • EVO $3.25
  • Resistance Level
  • TUYA $3.46
  • EVO $3.63
  • Average True Range (ATR)
  • TUYA 0.23
  • EVO 0.09
  • MACD
  • TUYA -0.11
  • EVO 0.00
  • Stochastic Oscillator
  • TUYA 10.94
  • EVO 25.58

Stock Price Comparison Chart: TUYA vs EVO

TUYA
EVO
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022242628TUYA VS EVO

About TUYA Tuya Inc. each representing one

Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, It has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use